Trikafta Increases Microbiome Diversity in Lungs, Study Shows

Trikafta Increases Microbiome Diversity in Lungs, Study Shows

312869

Trikafta Increases Microbiome Diversity in Lungs, Study Shows

The microbiome diversity in the lungs of cystic fibrosis (CF) patients increased after treatment with Trikafta, becoming similar to a person without CF, an analysis showed. In addition, small molecule metabolites produced by cells varied widely across patients while on the therapy, with the largest decrease seen in amino acids (building blocks of protein) or short chains of amino acids known as peptides. “A reduction of amino acids and peptides in lung mucus may be…

You must be logged in to read/download the full post.